In Special Issue 9 of 2019 E. Gray (Haemostasis Section, Biotherapeutics Group, National Institute for Biological Standards Control, South Mimms, Potters Bar UK) described the potency labelling of extended half-life FVIII and FIX products.
In Special Issue 9 of 2019 E. Gray (Haemostasis Section, Biotherapeutics Group, National Institute for Biological Standards Control, South Mimms, Potters Bar UK) described the potency labelling of extended half-life FVIII and FIX products.